MUSTANG BIO INC (MBIO) Stock Balance Sheet
NASDAQ:MBIO - Nasdaq - US62818Q3020 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 14.23M | 6.84M | 6.23M | 75.70M | 109.60M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 467.00K | 402.00K | 3.88M | 0.00 | 100.00K | |||
| Other Current Assets | 211.00K | 1.36M | 1.23M | 3.20M | 2.00M | |||
| Total Current Assets | 14.91M | 8.61M | 11.35M | 78.90M | 111.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 452.00K | 4.81M | 12.30M | 12.10M | |||
| Other Non-Current Assets | 0.00 | 250.00K | 1.58M | 1.30M | 1.40M | |||
| Total Non-Current Assets | 0.00 | 702.00K | 6.40M | 13.50M | 13.50M | |||
| TOTAL ASSETS | 14.91M | 9.31M | 17.74M | 92.40M | 125.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 3.33M | 3.55M | 8.31M | 7.60M | 6.70M | |||
| Accounts Payable | 6.31M | 7.46M | 6.32M | 6.80M | 3.50M | |||
| Other Current Liabilities | 1.51M | 1.60M | 739.00K | 600.00K | 600.00K | |||
| Total Current Liabilities | 11.15M | 12.61M | 15.37M | 15.10M | 10.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 27.40M | 0.00 | |||
| Other Non-Current Liabilities | 150.00K | 572.00K | 2.25M | 3.60M | 2.00M | |||
| Total Non-Current Liabilities | 150.00K | 572.00K | 2.25M | 31.00M | 2.00M | |||
| TOTAL LIABILITIES | 11.30M | 13.18M | 17.62M | 46.10M | 12.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -396.88M | -396.72M | -380.97M | -329.40M | -251.80M | |||
| Additional Paid In Capital | 400.49M | 392.23M | 380.50M | 374.50M | 359.90M | |||
| Common Shares | 0.00 | 616.00K | 592.00K | 1.10M | 4.30M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 3.37M | 1.83M | 9.64M | 8.13M | 7.25M | |||
| Tangible Book Value per Share | 1.07 | -2.11 | 0.01 | 5.86 | 15.83 | |||
| Total Shareholders' Equity | 3.61M | -3.87M | 123.00K | 46.30M | 112.40M | |||
| TOTAL LIABILITIES AND EQUITY | 14.91M | 9.31M | 17.74M | 92.40M | 125.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.59 | N/A | |||
| Current Ratio | 1.34 | 0.68 | 0.74 | 5.23 | 10.34 | |||
| Return On Assets (ROA) | -71.87% | -171.90% | -293.09% | -83.91% | -53.01% | |||
| Return On Equity (ROE) | -296.90% | N/A | -42276.42% | -167.45% | -59.05% | |||
All data in USD , ROIC based on taxRate of 0.21